Portfolio company
Endoriz
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Endoriz develops circadian-rhythm mimicking hormonal replacement therapies to treat patients with hypothyroidism and thyroid hormone deficiency.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Encellin
The company develops an encapsulated cell replacement therapy to deliver living medicines for patients with endocrine disorders such as type 1 diabetes.
Endometrics
Endometrics develops non-invasive diagnostic tests using menstrual blood samples and genomic biomarkers to detect endometriosis for women and healthcare providers.
ForEndo Pharma
The company develops hormone regulation therapies for women with endometriosis and polycystic ovary syndrome.
Crinetics
This pharmaceutical company develops oral therapeutics for patients with rare endocrine diseases and endocrine-related tumours.
Spruce Biosciences
This biopharmaceutical company develops enzyme replacement therapies and small molecules for patients with rare endocrine and neurological disorders.
Endogene.Bio
This company develops a biological data platform using menstrual blood to provide diagnostics and patient stratification tools for pharmaceutical firms and healthcare providers.
Endurance Bio
This biotechnology company develops oral small molecule therapeutics for patients with neurodegenerative and metabolic diseases to restore mitochondrial and lysosomal health.
GutCRINE
This company develops microbiome-derived pharmabiotics to treat metabolic and age-related disorders including obesity and type-2 diabetes for patients with chronic diseases.